Clinical Trials · NCT07727473

Preoperative Semaglutide Prior to Radical Prostatectomy

Name: Preoperative Semaglutide Prior to Radical Prostatectomy
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingEARLY_Phase 1Semaglutide

Phase: EARLY_Phase 1
Recruitment status: Not Yet Recruiting
Sponsor: Banner Health
Enrollment: 20
Start date: Jul 2026
Locations: 1 site, United States
Primary endpoint: Change in Caspase-3 (CC3) activation between baseline biopsy and radical prostatectomy specimen

View Semaglutide compound reference